PMC:7534795 / 45202-45481
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T205 | 58-68 | Body_part | denotes | fatty acid | http://purl.org/sig/ont/fma/fma82738 |
| T206 | 173-181 | Body_part | denotes | capsules | http://purl.org/sig/ont/fma/fma85272 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T335 | 86-94 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T349 | 25-46 | Chemical | denotes | Eicosapentaenoic acid | http://purl.obolibrary.org/obo/CHEBI_28364 |
| T350 | 42-46 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
| T351 | 48-51 | Chemical | denotes | EPA | http://purl.obolibrary.org/obo/CHEBI_28364|http://purl.obolibrary.org/obo/CHEBI_36006 |
| T353 | 58-68 | Chemical | denotes | fatty acid | http://purl.obolibrary.org/obo/CHEBI_35366 |
| T354 | 64-68 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
| T355 | 152-155 | Chemical | denotes | EPA | http://purl.obolibrary.org/obo/CHEBI_28364|http://purl.obolibrary.org/obo/CHEBI_36006 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T385 | 23-134 | Sentence | denotes | • Eicosapentaenoic acid (EPA) free fatty acid for hospitalized COVID-19 patients • Phase 3 interventional trial |
| T386 | 135-199 | Sentence | denotes | • Treatment with EPA gastro-resistant capsules vs. standard care |
| T387 | 200-225 | Sentence | denotes | • 28-day treatment period |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1315 | 95-103 | Species | denotes | patients | Tax:9606 |
| 1355 | 86-94 | Disease | denotes | COVID-19 | MESH:C000657245 |